Pharmaceutical Lithium Carbonate USP Capsules Filler from China
USP-grade lithium carbonate powder used as the active ingredient filler in capsule formulations for bipolar disorder treatment. Falls under HTS 2836.91.0010 due to its status as a chemically defined USP lithium carbonate, distinct from finished medicaments in Chapter 30.
Duty Rate — China → United States
28.7%
Rate breakdown
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Obtain FDA import alerts check for lithium compounds; provide batch-specific USP testing reports
• Ensure GMP-compliant packaging to prevent contamination
• Common pitfall: mislabeling as finished drug leading to Chapter 30 scrutiny